Should a 1‑year‑11‑month‑old child with a history of febrile seizures who is coinfected with COVID‑19 and influenza B be referred to the hospital for evaluation and management?

Hospital Referral Strongly Recommended

A 1-year-11-month-old child with a history of febrile seizures who is coinfected with COVID-19 and influenza B should be referred to the hospital for evaluation. This child meets multiple high-risk criteria that warrant hospital assessment, particularly given the combination of young age, prior febrile seizure history, and dual viral infection.

Key Risk Factors Present

This child has several concerning features that align with established admission criteria:

• Age under 2 years: Children under 2 years, particularly those under 1 year, have significantly higher admission rates (12 times higher than older children) and are at increased risk for complications 1, 2.

• History of febrile seizures: The child has a documented history of febrile fits, placing them at approximately 50% risk of recurrent febrile seizures given their young age 3. Influenza A is specifically associated with higher rates of febrile seizures (19.5%) and repeated seizures (28%) compared to other respiratory viruses 4.

• Dual viral coinfection: While viral co-detection doesn't uniformly indicate greater severity 5, the specific combination of COVID-19 and influenza B in this age group warrants closer observation. COVID-19 coinfection with influenza has been documented in pediatric populations, with 6% requiring hospitalization 6.

Specific Indicators for Hospital Admission

According to established pandemic influenza guidelines 1, 2, 1, hospital admission is indicated if the child displays any of the following:

Signs of Respiratory Distress

• Markedly raised respiratory rate
• Grunting
• Intercostal recession
• Breathlessness with chest signs

Other Critical Signs

• Cyanosis
• Severe dehydration
• Altered conscious level
• Complicated or prolonged seizure (particularly relevant given this child's history)
• Signs of septicemia (extreme pallor, hypotension, floppy infant)

Additional High-Risk Features

• Breathing difficulties
• Vomiting >24 hours
• Drowsiness

Clinical Assessment Priorities

Upon hospital presentation, the child should receive:

1. Vital signs monitoring: Assess for tachycardia, tachypnea, oxygen saturation, and fever patterns. Children with COVID-19 and FS tend to have higher body temperature, pulse, and respiratory rates 7.

2. Neurological evaluation: Given the febrile seizure history, assess for any neurologic deficits, change in mental status, or signs of encephalopathy. Complex febrile seizures occur in approximately 31-33% of COVID-19 cases with FS 8, 7.

3. Laboratory workup (if admitted):

   • Complete blood count with differential
   • Electrolytes (particularly sodium, as hyponatremia is associated with FS risk)
   • Blood culture if severely ill
   • Pulse oximetry

4. Respiratory virus confirmation: While already diagnosed, documentation of both pathogens guides management.

Treatment Considerations

If admitted, the child should receive:

• Antiviral therapy: Oseltamivir for influenza B (appropriate for children >1 year of age) 1, 2
• Antibiotic coverage: Co-amoxiclav for children under 12 years to cover S. pneumoniae, S. aureus, and H. influenzae if bacterial superinfection is suspected 2
• Supportive care: Oxygen therapy if SaO₂ ≤92%, IV fluids at 80% basal levels if unable to maintain oral intake
• Antipyretics: For fever management (avoid aspirin)

Common Pitfalls to Avoid

1. Don't assume viral coinfection is benign: While some studies suggest viral co-detection may be associated with lower severity 5, this child's young age and seizure history override this consideration.

2. Don't rely solely on antipyretics for seizure prevention: Antipyretics do not prevent febrile seizure recurrence during distant febrile episodes 3, 9.

3. Don't dismiss the seizure history: Influenza A (and likely influenza B) is associated with a 4.3-fold increased risk of repeated seizures compared to other respiratory viruses 4.

4. Monitor for deterioration: Even if initially well-appearing, children can decompensate. Transfer to HDU/PICU is indicated if the child fails to maintain SaO₂ >92% in FiO₂ >60%, develops shock, or shows evidence of encephalopathy 1.

Outpatient Management Only If

The child could potentially be managed as an outpatient only if they are truly well-appearing with:

• Stable vital signs
• No respiratory distress
• Adequate hydration
• Normal mental status
• Reliable caregiver capable of close monitoring and 12-24 hour follow-up 10

However, given this child's age (<2 years), seizure history, and dual infection, the threshold for admission should be very low, and hospital referral for evaluation is the prudent approach to ensure patient safety and prevent potential complications.